[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE406915T1 - Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler - Google Patents

Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler

Info

Publication number
ATE406915T1
ATE406915T1 AT02746091T AT02746091T ATE406915T1 AT E406915 T1 ATE406915 T1 AT E406915T1 AT 02746091 T AT02746091 T AT 02746091T AT 02746091 T AT02746091 T AT 02746091T AT E406915 T1 ATE406915 T1 AT E406915T1
Authority
AT
Austria
Prior art keywords
pancreatic juice
secretion
regulating
agent
lpa receptor
Prior art date
Application number
AT02746091T
Other languages
English (en)
Inventor
Shinji Nakade
Hiroshi Saga
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE406915T1 publication Critical patent/ATE406915T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
AT02746091T 2001-07-17 2002-07-16 Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler ATE406915T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001216133 2001-07-17

Publications (1)

Publication Number Publication Date
ATE406915T1 true ATE406915T1 (de) 2008-09-15

Family

ID=19050646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746091T ATE406915T1 (de) 2001-07-17 2002-07-16 Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler

Country Status (7)

Country Link
US (2) US20040171582A1 (de)
EP (1) EP1415667B1 (de)
JP (1) JPWO2003007991A1 (de)
AT (1) ATE406915T1 (de)
DE (1) DE60228732D1 (de)
ES (1) ES2312588T3 (de)
WO (1) WO2003007991A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050113283A1 (en) * 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
JPWO2004002530A1 (ja) * 2002-06-26 2005-10-27 小野薬品工業株式会社 慢性疾患治療剤
AU2003241836A1 (en) 2002-10-03 2004-04-23 Ono Pharmaceutical Co., Ltd. Lpa receptor antagonists
JP4692281B2 (ja) * 2003-08-05 2011-06-01 味の素株式会社 新規アゾール化合物
WO2005064332A1 (ja) * 2003-12-26 2005-07-14 Ono Pharmaceutical Co., Ltd. 高活性型リゾホスファチジン酸およびそれを用いたスクリーニング方法
JPWO2006103750A1 (ja) * 2005-03-29 2008-09-04 日本ハム株式会社 肥満改善用組成物、機能性食品及び医薬用組成物
WO2009082491A1 (en) * 2007-12-26 2009-07-02 Alp Life Sciences, Llc Nanovesontm: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases
JP5692746B2 (ja) 2008-08-07 2015-04-01 国立大学法人 長崎大学 全身性疼痛症候群の治療または予防薬
US8455499B2 (en) 2008-12-11 2013-06-04 Amira Pharmaceuticals, Inc. Alkyne antagonists of lysophosphatidic acid receptors
GB2466121B (en) * 2008-12-15 2010-12-08 Amira Pharmaceuticals Inc Antagonists of lysophosphatidic acid receptors
GB2470833B (en) * 2009-06-03 2011-06-01 Amira Pharmaceuticals Inc Polycyclic antagonists of lysophosphatidic acid receptors
US8592402B2 (en) 2009-08-04 2013-11-26 Amira Pharmaceuticals, Inc. Compounds as lysophosphatidic acid receptor antagonists
GB2474748B (en) 2009-10-01 2011-10-12 Amira Pharmaceuticals Inc Polycyclic compounds as lysophosphatidic acid receptor antagonists
GB2474120B (en) 2009-10-01 2011-12-21 Amira Pharmaceuticals Inc Compounds as Lysophosphatidic acid receptor antagonists
US8541587B2 (en) 2011-04-05 2013-09-24 Amira Pharmaceuticals, Inc. Lysophosphatidic acid receptor antagonists
CN104066729A (zh) 2011-08-15 2014-09-24 英特穆恩公司 溶血磷脂酸受体拮抗剂
JP6139781B2 (ja) * 2014-04-04 2017-05-31 国立大学法人大阪大学 リゾリン脂質受容体を活性化する物質を含有する薬剤送達促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324972A1 (en) * 1997-12-30 1999-07-15 Nps Allelix Corp. Identification of lysolipid receptors involved in inflammatory response
US6380177B1 (en) * 1999-06-25 2002-04-30 Atairgin Technologies, Inc. LPA analogs as agonists of the Edg2 LPA receptor
AU2001232340A1 (en) * 2000-02-18 2001-08-27 Kirin Beer Kabushiki Kaisha Novel isoxazole and thiazole compounds and use thereof as drugs
EP1263752B1 (de) * 2000-03-17 2007-12-05 The University Of Tennessee Research Corporation Agonisten und antagonisten für den lpa-rezeptor und anwendungsmethoden
EP1364659B1 (de) * 2001-02-08 2009-11-11 Ono Pharmaceutical Co., Ltd. Mittel zur behandlung von harnwegserkrankungen, umfassend mittel zur kontrolle des lpa-rezeptors

Also Published As

Publication number Publication date
ES2312588T3 (es) 2009-03-01
US20040171582A1 (en) 2004-09-02
DE60228732D1 (de) 2008-10-16
JPWO2003007991A1 (ja) 2004-11-04
EP1415667B1 (de) 2008-09-03
WO2003007991A1 (fr) 2003-01-30
US20080234230A1 (en) 2008-09-25
EP1415667A4 (de) 2006-04-19
EP1415667A1 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
ATE406915T1 (de) Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler
DE60321318D1 (de) Gewinnung von delta-9 tetrahydrocannabinol
UA40587C2 (uk) Метансульфонат (е)-3-[2-h-бутил-1{(4-карбоксифеніл)метил}-1н-імідазол-5-іл]-2-(2-тієніл)метил-2-пропенової кислоти, спосіб його одержання, фармацевтична композиція на його основі
DK1104294T3 (da) Sammensatninger og Fremgangsmåder til behandling af unormal celleproliferation
PL285591A1 (en) Method for manufacturing new imidazolilalkenecrbxylic acids
AU640417B2 (en) Substituted 5-((tetrazolyl)alkenyl)imidazoles
TW200618509A (en) System, apparatus, computer program product and method for controlling terminal output power
BR9712637A (pt) Método e equipamento para efetuar um movimento rápido para baixo em um sistema de controle de potência da ligação enviada de um telefone celular
WO2003053922A3 (en) Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
TW201922244A (zh) 治療貧血之組合物及方法
UA49880C2 (uk) Дигідрат ерпоcартану, фармацевтична композиція, спосіб отримання твердої дозованої форми, спосіб блокування рецепторів ангіотензину іі
HUT56077A (en) Process for producing n-(imidazolyl-alkyl)-alanyl derivatives with substituents and pharmaceutical compositions containing them as active components
MY129355A (en) Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
WO2004041208A3 (en) Controlled absorption of mixed thyroyd hormone formulations
Crook et al. Stimulation of Na+, K+, Cl-cotransport by forskolin-activated adenylyl cyclase in fetal human nonpigmented epithelial cells.
EP1541171A4 (de) Mittel zur behandlung von diabetes mellitus
PE20011260A1 (es) Derivados de sulfonamida
AU2003275495A8 (en) Methods of treating injuries of the nervous system associated with hemorrhage
Samuelsson-Almen et al. Pituitary adenylate cyclase-activating polypeptide-and vip-induced activation of adenylate cyclase in the porcine non-pigmented ciliary epithelium: effects of antagonists
Chapleau Cardiovascular mechanoreceptors
NO20003931L (no) Hydroksam- og karboksylsyrederivater
EP1501791A4 (de) Aminosäureanaloga
WO2005112998A3 (en) Compositions and methods for preventing erythropoietin-associated hypertension
Helwig et al. Evidence of bPTH-(1–34) Sensitive Adenylate Cyclase in Isolated Rabbit Renal Cortex Arterioles
TW200619436A (en) Plating apparatus and method for autofeeding solution

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties